Clinical Trials Logo

Depressive Disorder clinical trials

View clinical trials related to Depressive Disorder.

Filter by:

NCT ID: NCT03088319 Completed - Clinical trials for Depression, Postpartum

Post-natal Depression and Chronic Stress

serene
Start date: April 11, 2017
Phase:
Study type: Observational

The risk of emergence of a post natal depression is based on an interaction between a maternal psychic vulnerability and a chronic environmental context of stress. The PND appears as a relevant model for studying the mechanisms of chronic stress and vulnerability to psychological pathologies. This study aim to follow a cohort of pregnant women to determine the predictive psychobiological factors of the emergence of postnatal depression

NCT ID: NCT03087916 Recruiting - Clinical trials for Major Depressive Disorder (MDD)

Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder

Start date: June 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

NCT ID: NCT03084744 Recruiting - Dysthymic Disorder Clinical Trials

Schema Therapy for Chronic Depression

Start date: August 21, 2017
Phase: N/A
Study type: Interventional

To compare the efficacy of schema therapy versus active monitoring for women with chronic depression receiving psychiatric care.

NCT ID: NCT03084042 Recruiting - Clinical trials for Major Depressive Disorder

Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety

Start date: July 2016
Phase:
Study type: Observational

This study aims to 1) examine common and specific emotional and cognitive dysfunctions between Major Depression and generalized anxiety disorder; 2) Examine emotional and cognitive dysfunctions between the two disorders and healthy controls; 3) Examine the biomarkers predicting successful therapy or not.

NCT ID: NCT03080025 Completed - Depression Clinical Trials

Social Interaction and Compassion in Depression

SIDE
Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how a CBCT® (Cognitively Based Compassion-Training) for couples affect aspects of health and especially social interactions in depressed female patients and their romantic partners. compare healthy and depressed couples during an instructed positive real-time social interaction in the laboratory. Furthermore the investigators aim to examine how social behavior and psychobiological indicators of health during real-time social interaction in the laboratory might be improved through CBCT® for couples.

NCT ID: NCT03079895 Completed - Depression Clinical Trials

Thrive Care: Internet CBT for Depression

Start date: April 13, 2017
Phase: N/A
Study type: Interventional

This project will study the effectiveness of computerized cognitive behavioral therapy (CBT) in reducing depression symptoms. The design is a two-arm randomized controlled trial comparing (i) control arm, which is treatment as usual with (ii) treatment arm, which is treatment as usual plus computerized CBT. The primary outcome measure is change in depression symptom severity. The name of the computerized CBT program to be used in the study is Thrive.

NCT ID: NCT03079297 Terminated - Clinical trials for Major Depressive Disorder

Rapid Antidepressant Effects of Leucine

Start date: March 9, 2017
Phase: Phase 2
Study type: Interventional

This randomized double-blind placebo-controlled crossover study seeks to evaluate the antidepressant effect of L-leucine, an essential amino acid, in patients with Major Depressive Disorder (MDD).

NCT ID: NCT03078322 Completed - Clinical trials for Major Depressive Disorder

AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression

ELEVATE
Start date: March 5, 2018
Phase: Phase 2
Study type: Interventional

The study will evaluate the safety and efficacy of AV-101.

NCT ID: NCT03072823 Completed - Clinical trials for Cardiovascular Diseases

Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases

Start date: January 27, 2016
Phase: N/A
Study type: Interventional

N-3 polyunsaturated fatty acids(N-3 PUFAs) is important in balancing the immune function and physical health by reducing membrane arachidonic acid (AA) and prostaglandin E2 (PGE2) synthesis, which might be linked to the somatic manifestations physical morbidity, such as Cardiovascular disease in depression. n-3 polyunsaturated fatty acids appears to be a promising treatment that is safe, beneficial to patients with Cardiovascular disease and depression. In this proposal, investigators aim the test the hypothesis that n-3 polyunsaturated fatty acids will be more effective than placebo in treating Cardiovascular disease patients with major depression after 12 weeks of intervention.

NCT ID: NCT03071562 Completed - Depression Clinical Trials

A Randomized Pilot Trial Evaluating the Impact of a Yoga Intervention on Cognition in Older Adults Infected With HIV

Start date: January 2017
Phase: N/A
Study type: Interventional

Approximately 50% of people living with HIV (and as many as 80% over the age of 50) have difficulties with cognitive functions such as memory and thinking that can have a profound negative impact on activities of daily living and quality of life. Problems with memory and thinking are also associated with forgetting to take anti-retroviral drugs and experiencing challenges to balance, walking and mental health (anxiety and depression). There is increasing evidence that, in the general population, exercise has positive effects on cognition, physical functioning and mental health. Despite the recognition of multiple therapeutic benefits of exercise, little attention has been paid to its possible effects on cognition in people living with HIV. The purpose of the proposed pilot study is to compare the effects of a 12-week, randomly assigned, community-based yoga-mindfulness intervention on cognition, balance, walking, mental health and quality of life in 30 people >35 years of age living with HIV in the Halifax area. Yoga is of particular interest because it encompasses not only the physical but also spiritual, emotional, and mental dimensions of life. As such, it has tremendous potential to help stave off some of the devastating consequences of HIV infection.